SELLAS Life Sciences Group, Inc. (SLS)

5.53 +0.25 (+4.73%) USD  |  NASDAQ  |  Mar 06, 16:00
5.52 -0.01 (-0.18%) After-Hours: 20:00
More

SELLAS Life Sciences Group Net Debt Issuance (Annual)

Net Debt Issuance (Annual) Chart

View Net Debt Issuance (Annual) for SLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Debt Issuance (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Debt Issuance (Annual) Range, Past 5 Years

View Net Debt Issuance (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Debt Issuance (Annual) Benchmarks

View Net Debt Issuance (Annual) Benchmarks
Start Trial
Amicus Therapeutics, Inc. Upgrade
Vanda Pharmaceuticals, Inc. Upgrade
GT Biopharma, Inc. Upgrade
ADMA Biologics, Inc. Upgrade
Lyell Immunopharma, Inc. Upgrade